Cargando…
Prisoners should not be left behind in HCV research and policies
With a worldwide prevalence of 15.4%, hepatitis C virus (HCV) has been estimated to be the most prevalent major infectious disease in prisons. The exceptionally high prevalence of HCV in prisons is attributable to common risk behaviors including sharing contaminated tattooing equipment and drug para...
Autores principales: | Moazen, Babak, Stöver, Heino, Dolan, Kate, Jahn, Albrecht, Neuhann, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245876/ https://www.ncbi.nlm.nih.gov/pubmed/32448290 http://dx.doi.org/10.1186/s12954-020-00379-y |
Ejemplares similares
-
Principles of condom provision programs in prisons from the standpoint of European prison health experts: a qualitative study
por: Moazen, Babak, et al.
Publicado: (2021) -
Drug use and opioid substitution treatment for prisoners
por: Stöver, Heino, et al.
Publicado: (2010) -
Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe
por: Stöver, H., et al.
Publicado: (2019) -
HCV infected prisoners: should they be still considered a difficult to treat population?
por: Iacomi, Fabio, et al.
Publicado: (2013) -
Metformin-induced lactic acidosis: no one left behind
por: Vecchio, Sarah, et al.
Publicado: (2011)